脑部放疗，上午比下午敏感许多！/ ]: k1 D5 i) L' o+ J$ k" w) q
' V# g; I8 C5 j7 n/ A( w( z# j* W+ G: @/ Y/ Q
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
# x8 B" C; i4 N5 q* K. l2 B1 rGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?& y; J/ ]/ l8 V8 N- f( U, ^4 P
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.0 |% b8 w2 B' | X
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA." V3 a; Z& W; ], W6 D; ^; r
4 _! q w' |/ n+ d
Abstract1 {7 s( W) U9 {$ l7 J& ~; W. W R
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time./ o# Z" Y) m+ g7 R B3 T* x! z
& k. f" H* l7 q5 o0 RMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.# L% O- x3 J, w0 {2 Y
; w7 N5 Q% K' J: ^
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
: q' Y+ L! L3 x6 Z7 D" z* C
) T2 I) N% y! X) {: fCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
4 u9 Q7 Z4 X- |9 j/ z1 \
% m* c4 S+ r1 a; [" G |
9 n' ~; j: i( U6 L
显身卡
